Psilocybin
COMP 401
Phase 2 small_molecule completed
Quick answer
Psilocybin for Anorexia Nervosa is a Phase 2 program (small_molecule) at Compass Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Anorexia Nervosa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed